8-K: Spectral Capital Acquires Quantum Nanophotonics Technology, Appoints Dr. Moshik Cohen as CTO

Spectral Capital Corporation has acquired plasmonics and quantum nanophotonics technology and appointed Dr. Moshik Cohen as Chief Technology Officer to accelerate the development of high-speed computing solutions.

Summary

• Spectral Capital Corporation has entered into a definitive agreement to acquire intellectual property related to plasmonics and quantum nanophotonics from Verdant Quantum, an Estonian company.
• The acquired technology, developed by Dr. Moshik Cohen, is designed to significantly increase the processing speed of classical computers.
• In exchange for the IP, Spectral will issue 10,000,000 common shares to Verdant, subject to a 36-month lock-up period with an initial liquidity window of 100,000 shares.
• Dr. Moshik Cohen will be appointed as Chief Technology Officer of Spectral and CEO of a new Israeli subsidiary, Verdant IL.
• Dr. Cohen's annual salary will be $240,000, with potential bonuses up to $1,000,000, and he will be granted options to purchase 2,000,000 common shares.
• Upon listing on the NASDAQ or NYSE, Spectral will invest $25 million into Verdant IL on a milestone basis.
• The company has 30 days to issue the 10,000,000 shares to Verdant.
• After the share issuance, there will be 81,742,516 common shares outstanding.

Sentiment

Score: 8

Explanation: The document conveys a highly positive sentiment due to the acquisition of promising technology, the appointment of a renowned expert, and the potential for significant advancements in computing speed. The future investment also indicates strong growth potential.

Positives

• The acquisition of the plasmonics and quantum nanophotonics technology has the potential to significantly enhance the processing speed of classical computers.
• The appointment of Dr. Moshik Cohen as CTO brings a globally recognized expert in the field to Spectral.
• The technology has demonstrated ultra-fast data transfer, energy efficiency, and room-temperature operation.
• The agreement includes a $25 million investment into a new subsidiary upon listing on a major exchange, indicating future growth potential.
• The lock-up agreement on the shares issued to Verdant provides stability and reduces the risk of immediate dilution.

Negatives

• The company has not yet issued the required common stock purchase options to the Inventor.
• The company has not yet approved the issuance of the 10,000,000 common shares to Verdant.
• The agreement is subject to a 90-day technical due diligence period where the company can cancel the agreement if the IP is not viable.

Risks

• The technology is still in development and may not achieve the expected performance or commercial success.
• The company's ability to successfully integrate the acquired technology and commercialize it is not guaranteed.
• The company's future listing on the NASDAQ or NYSE is not guaranteed.
• The company's ability to raise the $25 million investment is not guaranteed.
• The company has 90 days to determine if the IP is viable, which could lead to the termination of the agreement.

Future Outlook

Spectral Capital aims to transform itself into a deep-tech holding company by leveraging the acquired technology and Dr. Cohen's expertise to bridge the gap between classical and quantum computing. The company plans to provide further updates on its advancements and share a technological roadmap in the near term.

Management Comments

• Sean Michael Brehm, Chairman of Spectral Capital, stated that Dr. Cohen's expertise will transform Spectral from a Quantum as a Service Company to a Deep-tech holding company.
• Dr. Moshik Cohen stated that Spectral's vision aligns perfectly with the potential of plasmonics and that they are on the cusp of enabling classical systems to achieve near-quantum-level speeds.
• Jenifer Osterwalder, CEO of Spectral Capital, stated that Dr. Cohen's work will accelerate Spectral's current Quantum Bridge initiative and deliver next-generation technologies.

Industry Context

This announcement positions Spectral Capital as a player in the emerging field of quantum computing and advanced computing technologies. The acquisition of plasmonics technology aligns with the industry trend of exploring alternative methods to enhance computing speed and efficiency beyond traditional silicon-based systems. The appointment of a recognized expert like Dr. Cohen also signals a commitment to innovation and technological advancement.

Comparison to Industry Standards

• While companies like Intel and Samsung have invested in neuromorphic computing and AI-driven systems, Spectral's focus on plasmonics for near-light-speed data transfer is a unique approach.
• Companies like IBM and Google are heavily invested in quantum computing, Spectral is taking a different approach by focusing on enhancing classical computing with quantum-inspired technologies.
• The field of plasmonics is still relatively nascent, making direct comparisons difficult, but the claimed performance of near-light-speed data transfer is significantly faster than current industry standards.
• The $25 million investment into Verdant IL upon listing is a significant commitment, comparable to early-stage funding rounds in other deep-tech startups.

Management Changes

Stakeholder Impact

• Shareholders may benefit from the potential increase in the company's value due to the acquisition and technological advancements.
• Employees may have new opportunities for growth and development within the company.
• Customers may benefit from the development of faster and more efficient computing solutions.
• Suppliers may see increased demand for their products and services.
• Creditors may see an improvement in the company's financial stability.

Next Steps

• The company will issue 10,000,000 common shares to Verdant within 30 days.
• The company will request that the board issue 2,000,000 options to purchase shares to Dr. Cohen.
• The company will conduct technical due diligence on the acquired IP within 90 days.
• The company will invest $25 million into Verdant IL within 30 days of listing on the NASDAQ or NYSE.
• The company will provide further updates on its advancements and share a technological roadmap in the near term.

Key Dates

Keywords

quantum computing, plasmonics, nanophotonics, intellectual property, technology acquisition, chief technology officer, data transmission, computer processing, deep tech, quantum as a service